Cephalon shares fall on 2Q report (Boston Globe)

Shares of Cephalon Inc. fell sharply Wednesday after the biotechnology company posted a second-quarter loss on a hefty reserve related to the settlement of a government probe.

Original post by Lyle

This entry was posted on Thursday, August 2nd, 2007 at 12:45 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.